Intellipharmaceutics Announces Downgrade to OTC Expert Marke

Intellipharmaceutics Announces Downgrade to OTC Expert Market

TORONTO, ON / ACCESSWIRE / June 14, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI.H) ("Intellipharmaceutics" or the "Company"), announced today that its common stock, currently traded on the OTCQB market, is expected to be downgraded to the OTC Expert Market on June 1...

Related Keywords

United States , Toronto , Ontario , Canada , Isa Odidi , Company Contact , Regulation Services Provider , Ontario Securities Commission On , Venture Exchange , Intellipharmaceutics International Inc , Intellipharmaceutics International , Expert Market , Best Execution , Limit Orders , Ontario Securities Commission , Point Of Divergence Drug Delivery System , Securities Act ,

© 2025 Vimarsana